RS2 Healthcare Partners Invests in KMM Group and Names J. Mark King CEO
RS2 Healthcare Partners, a distinguished private equity firm based in Boston, has successfully finalized its investment in KMM Group, a cutting-edge precision contract manufacturer located in Hatboro, Pennsylvania. This strategic move places RS2 at the forefront of a rapidly evolving healthcare manufacturing landscape, emphasizing its long-term commitment to investing exclusively in lower middle market healthcare businesses.
KMM Group has established itself as a vital player in the medical device sector, renowned for its capabilities in producing complex, high-precision components. With a solid reputation, a broad spectrum of blue-chip clients, and a dedicated workforce, KMM is poised for transformative growth with the support of RS2 Healthcare Partners.
Craig Stern, Co-Managing Partner at RS2, expressed enthusiasm about the partnership, highlighting KMM's exceptional market standing and specialized offerings. He noted the firm's mission is to enhance the company's operational efficiencies while maintaining the cultural and operational integrity that has defined KMM.
In conjunction with the investment, J. Mark King has been appointed President and CEO of KMM Group. King brings over three decades of industry experience, previously serving as the head of Tegra Medical, another significant contract manufacturer in the medical field and a former RS2 portfolio company. His experience and existing relationships with the RS2 team are expected to foster successful collaboration moving forward.
"I am deeply honored to lead KMM into its next growth phase," said King. "My history with RS2 Healthcare Partners and advisory role with KMM has equipped me with unique insights to build on the company's momentum. Together with John Shegda and Eric Wilhelm, the co-founders of KMM, I am committed to enhancing our product capabilities and fortifying our position as a premier manufacturer for the medtech sector."
John Shegda, one of KMM's founders, welcomed the partnership with RS2, emphasizing the need for a partnership that would enhance their vision and mission. In his remarks, he stated that the rapid evolution of manufacturing requires the firm to innovate continuously, and partnering with RS2 provides the essential experience and relationships to achieve that goal.
Eric Wilhelm, also a co-founder, reiterated the commitment to uphold the core values and manufacturing excellence that characterize KMM. As the newly appointed Executive Vice President in charge of Business Transformation, he aims to strengthen operational capabilities while focusing on sustainable growth.
This investment not only marks a significant chapter for KMM Group but also signals RS2’s strategic focus on tapping into the growing healthcare sector, which is increasingly geared towards innovative manufacturing processes.
In conclusion, RS2 Healthcare Partners' latest investment and the leadership appointment of J. Mark King align with the firm's aim to forge ahead in the healthcare manufacturing space. The partnership promises to drive innovations and improvements in manufacturing standards, potentially reshaping the landscape of the medical device market.
For further insights on KMM Group and their innovative manufacturing capabilities, visit kmmgrp.com. To learn more about RS2 Healthcare Partners and their investment strategy, explore rs2healthcare.com.
KMM Group has established itself as a vital player in the medical device sector, renowned for its capabilities in producing complex, high-precision components. With a solid reputation, a broad spectrum of blue-chip clients, and a dedicated workforce, KMM is poised for transformative growth with the support of RS2 Healthcare Partners.
Craig Stern, Co-Managing Partner at RS2, expressed enthusiasm about the partnership, highlighting KMM's exceptional market standing and specialized offerings. He noted the firm's mission is to enhance the company's operational efficiencies while maintaining the cultural and operational integrity that has defined KMM.
In conjunction with the investment, J. Mark King has been appointed President and CEO of KMM Group. King brings over three decades of industry experience, previously serving as the head of Tegra Medical, another significant contract manufacturer in the medical field and a former RS2 portfolio company. His experience and existing relationships with the RS2 team are expected to foster successful collaboration moving forward.
"I am deeply honored to lead KMM into its next growth phase," said King. "My history with RS2 Healthcare Partners and advisory role with KMM has equipped me with unique insights to build on the company's momentum. Together with John Shegda and Eric Wilhelm, the co-founders of KMM, I am committed to enhancing our product capabilities and fortifying our position as a premier manufacturer for the medtech sector."
John Shegda, one of KMM's founders, welcomed the partnership with RS2, emphasizing the need for a partnership that would enhance their vision and mission. In his remarks, he stated that the rapid evolution of manufacturing requires the firm to innovate continuously, and partnering with RS2 provides the essential experience and relationships to achieve that goal.
Eric Wilhelm, also a co-founder, reiterated the commitment to uphold the core values and manufacturing excellence that characterize KMM. As the newly appointed Executive Vice President in charge of Business Transformation, he aims to strengthen operational capabilities while focusing on sustainable growth.
This investment not only marks a significant chapter for KMM Group but also signals RS2’s strategic focus on tapping into the growing healthcare sector, which is increasingly geared towards innovative manufacturing processes.
In conclusion, RS2 Healthcare Partners' latest investment and the leadership appointment of J. Mark King align with the firm's aim to forge ahead in the healthcare manufacturing space. The partnership promises to drive innovations and improvements in manufacturing standards, potentially reshaping the landscape of the medical device market.
For further insights on KMM Group and their innovative manufacturing capabilities, visit kmmgrp.com. To learn more about RS2 Healthcare Partners and their investment strategy, explore rs2healthcare.com.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.